GLP-1 Medications: Every Option Explained for Weight Loss and Diabetes

GLP-1 medications are the most talked-about weight loss treatment in years. But most of what you read online is either oversimplified marketing or dense clinical jargon that does not help you make a decision.

This is the practical version. What GLP-1 medications actually are, which ones exist, how they differ, and what a real treatment program looks like when it is done right.

What Is GLP-1?

GLP-1 stands for glucagon-like peptide-1. It is a hormone your body produces in the gut after you eat. When GLP-1 is released, it does three things:

• Signals your brain that you are full
• Slows how quickly food leaves your stomach
• Tells your pancreas to release insulin at the right time

In people with obesity or metabolic dysfunction, GLP-1 signaling is often weaker than it should be. You eat a meal, but the fullness signal arrives late or gets drowned out. The result is overeating that has nothing to do with discipline.

GLP-1 medications are synthetic versions of this hormone. They bind to the same receptors as natural GLP-1 but last much longer in your body, typically about a week per injection. That keeps the fullness signal active around the clock.

Every GLP-1 Medication Available in 2026

The GLP-1 drug class has grown significantly. Here is every FDA-approved option, what it treats, and how it is taken.

Semaglutide (single GLP-1 receptor agonist)

• Ozempic — weekly injection, approved for type 2 diabetes. Max dose: 2 mg.
• Wegovy — weekly injection, approved for chronic weight management. Max dose: 2.4 mg.
• Rybelsus — daily oral tablet, approved for type 2 diabetes. The only GLP-1 available as a pill.

All three contain the same molecule (semaglutide). The difference is dosing, delivery method, and what they are FDA-approved to treat. Read how semaglutide works in the body for a deeper look at the mechanism.

Tirzepatide (dual GLP-1 + GIP receptor agonist)

• Mounjaro — weekly injection, approved for type 2 diabetes.
• Zepbound — weekly injection, approved for chronic weight management.

Tirzepatide targets two receptors instead of one. The addition of the GIP receptor appears to enhance fat metabolism, improve insulin response, and may reduce GI side effects for some patients. In clinical trials, tirzepatide produced greater average weight loss than semaglutide. Learn how tirzepatide's dual agonist mechanism works.

Older GLP-1 medications

• Liraglutide (Victoza for diabetes, Saxenda for weight loss) — daily injection, largely replaced by weekly options
• Dulaglutide (Trulicity) — weekly injection for diabetes
• Exenatide (Byetta, Bydureon) — twice-daily or weekly injection for diabetes
• Lixisenatide (Adlyxin) — daily injection for diabetes

Semaglutide and tirzepatide dominate current prescribing because they produce stronger results with once-weekly dosing.

GLP-1 for Weight Loss vs Diabetes

GLP-1 medications were originally developed for type 2 diabetes. The weight loss was a side effect that turned out to be significant enough to earn its own FDA approval.

The distinction matters for two reasons:

• Indication determines the brand. Ozempic is for diabetes. Wegovy is the same molecule approved for weight loss at a slightly higher dose. Your provider chooses based on your diagnosis and insurance.
• Insurance coverage differs. Diabetes indications are covered by most plans. Weight management indications have more limited coverage, though this is changing.

Regardless of why you start, the metabolic benefits overlap. Patients using GLP-1 medications for weight loss often see improvements in blood sugar, blood pressure, and cholesterol even if they were never diagnosed with diabetes.

What the Clinical Trials Show

The evidence base for GLP-1 medications is large. The two most relevant trial programs:

STEP trials (semaglutide): Patients lost an average of 15% body weight over 68 weeks. Cardiovascular event risk dropped by 20% in high-risk patients.

SURMOUNT trials (tirzepatide): Patients lost up to 22.5% body weight at the highest dose over 72 weeks. Improvements in A1C, blood pressure, and triglycerides were statistically significant across all dose groups.

For a detailed head-to-head breakdown, read our semaglutide vs tirzepatide comparison.

Benefits Beyond Weight Loss

GLP-1 medications affect more than appetite. Clinical data shows benefits across multiple systems:

• Cardiovascular: Reduced risk of heart attack, stroke, and cardiovascular death in high-risk patients. Semaglutide's SELECT trial showed a 20% reduction in major cardiovascular events.
• Blood sugar: Improved A1C and fasting glucose, even in patients without a diabetes diagnosis.
• Blood pressure: Modest but consistent reductions across trials.
• Inflammation: Lower CRP and inflammatory markers. Tirzepatide in particular has shown anti-inflammatory properties beyond what weight loss alone would explain.
• Liver health: Reduction in liver fat (hepatic steatosis) in patients with fatty liver disease.

These benefits are why GLP-1 medications are increasingly viewed as metabolic treatments, not just weight loss drugs.

Side Effects to Know About

Both semaglutide and tirzepatide share similar side effect profiles. The most common:

• Nausea (peaks in weeks 1-4, usually resolves)
• Constipation or diarrhea
• Stomach discomfort
• Reduced appetite (intended effect, but can feel intense initially)

Slow dose titration, starting low and increasing every 4 weeks, significantly reduces these effects. Serious adverse events (pancreatitis, gallbladder issues) are rare but monitored through regular lab work. Read our full side effects guide for detailed rates and management tips.

Why a Prescription Alone Is Not Enough

Most GLP-1 clinics write a prescription and send you home. The weight comes off for a few months. Then it stalls, or you stop the medication and regain.

The reason is that GLP-1 medications address appetite, but appetite is only one driver of weight. If your thyroid is underperforming, if insulin resistance is the primary issue, if cortisol is chronically elevated, if you are losing muscle mass alongside fat, the medication alone will not produce lasting results.

At Med Matrix, every GLP-1 program starts with a 100-biomarker lab panel and an InBody 770 body composition scan. Your provider reviews the full picture before prescribing anything. If GLP-1 medication fits your profile, it becomes one piece of a protocol that also addresses hormones, nutrients, body composition, and metabolic root causes.

Kim started on semaglutide and described the shift: the food noise just went away. But her program also included body composition tracking, nutrition guidance, and ongoing labs. Anthony lost 37 pounds on tirzepatide, but his team also caught that he was a point away from pre-diabetes, something no previous doctor had found.

Our GLP-1 and weight loss podcast covers how we approach these medications differently, including natural GLP-1 triggers like fiber that complement treatment.

FAQs

What are GLP-1 medications?

GLP-1 medications are injectable drugs (and one oral tablet) that mimic the GLP-1 hormone your body produces after eating. They reduce appetite, slow stomach emptying, and help regulate blood sugar and insulin. Common brands include Ozempic, Wegovy, Mounjaro, and Zepbound.

What is the strongest GLP-1 medication for weight loss?

Tirzepatide (Mounjaro/Zepbound) produced the highest average weight loss in clinical trials, up to 22.5% body weight. It targets two receptors (GLP-1 and GIP) compared to semaglutide's one. However, individual responses vary, and the best choice depends on your lab results.

Can you take GLP-1 as a pill?

Yes. Rybelsus is an oral semaglutide tablet taken daily. It is currently approved for type 2 diabetes. The injectable forms (Wegovy, Zepbound) are more commonly used for weight management because they produce stronger results at higher doses.

Are GLP-1 medications safe long-term?

Clinical trials lasting 1-2 years showed a favorable safety profile for both semaglutide and tirzepatide. The most common side effects are GI-related and typically resolve. Serious events (pancreatitis, gallbladder) are rare. Long-term studies beyond 2 years are ongoing. Lab monitoring throughout treatment helps catch issues early.

Do GLP-1 medications help with heart health?

Yes. The SELECT trial showed semaglutide reduced major cardiovascular events by 20% in patients with obesity and existing heart disease. Both semaglutide and tirzepatide improve blood pressure, cholesterol, and inflammatory markers.

How much do GLP-1 medications cost?

Brand-name pricing ranges from roughly $1,000-$1,600/month without insurance. Compounded versions from 503B-registered pharmacies can be significantly cheaper when available. At Med Matrix, onboarding (labs + consultation) runs $1,200-$1,500 and medication cost is separate. We accept HSA, FSA, CareCredit, and all major cards.

Med Matrix offers GLP-1 programs across Maine and New Hampshire, including South Portland, Freeport, and Rochester, NH.

Get Your Free Guide + $100 Voucher to start with the lab work that tells you which approach is right for your body.